Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brandes, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brandes, J. L.
NEUROLOGY 2003;61:S21-S26
© 2003 American Academy of Neurology

Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology.

Treatment approaches to maximizing therapeutic response in migraine

Jan Lewis Brandes, M.D.

From the Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN.

Address correspondence and reprint requests to Dr. Jan Lewis Brandes, 300 20th Avenue North, Suite 603, Nashville, TN 37203.

Migraine is a chronic condition that presents with episodic disabling attacks, which can respond unpredictably to therapies. Studies support early treatment intervention strategies as part of the routine clinical care of migraine patients. Identifying illness severity and stratifying treatment accordingly (as in other diseases such as asthma, diabetes, or hypertension) improves patient outcome. Assessing the presence of any coexisting conditions, such as depression or anxiety, is another essential part of managing migraine.


Publication of this supplement was supported by an unrestricted educational grant from AstraZeneca Pharmaceuticals.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.